We have heard from many recipients of the Biomet M2a Magnum hip who have suffered premature device failure, metallosis and other serious complications. We expect to file additional Biomet hip lawsuits in this litigation in the future.
New York, New York (PRWEB) March 04, 2013
Bernstein Liebhard LLP announces that they have filed a Biomet hip replacement lawsuit on behalf of a recipient of the Biomet M2a Magnum hip implant. The complaint was filed on March 1st in the multidistrict litigation established in U.S. District Court, Northern District of Indiana for all federally-filed Biomet hip implant lawsuits. Court records indicate that at least 141 claims are currently pending in the federal Biomet M2a Magnum hip implant litigation. Last month, the Court issued a Case Management Order allowing Biomet hip replacement lawsuits to be filed directly in the Northern District of Indiana. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We have heard from many recipients of the Biomet M2a Magnum hip who have suffered premature device failure, metallosis and other serious complications. We expect to file additional Biomet hip lawsuits in this litigation in the future,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal reviews to individuals allegedly injured by the metal-on-metal hip implant Magnum M2a hip.
Biomet Hip Implant Lawsuits
The Biomet M2a Magnum Hip is a metal-on-metal hip implant system, in which the ball and cup consist of a chromium/cobalt alloy. Like other claims pending in the federal litigation, the Biomet hip replacement lawsuit filed by Bernstein Liebhard LLP alleges the all-metal design of the M2a Magnum can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device.
The safety of the Biomet M2a Magnum and other metal-on-metal hips is currently being reviewed by the U.S. Food & Drug Administration (FDA). On January 17, 2013, the agency issued new guidance for patients with metal-on-metal hips, advising doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. The FDA has also proposed a new regulation that would make all-metal hips ineligible for its 510(k) approval system, which allowed products like the Biomet M2a Magnum hip implant to come to market without human testing.*
Biomet is just one of several manufacturers that have been named a defendant in product liability claims involving metal hip replacements. The lawyers at Bernstein Liebhard LLP are actively filing claims in the multidistrict litigation established in the U.S. District Court, Northern District of Ohio, for actions involving the DePuy ASR hip implant (MDL No. 2197). The firm is also involved in the federal litigation underway in the Northern District of Texas concerning the metal-on-metal DePuy Pinnacle hip device (MDL No. 2244). Bernstein Liebhard LLP partner Jeffrey S. Grand is serving on the Plaintiffs’ Steering Committee in the Pinnacle hip litigation.
Free case evaluations are also being offered to patients impacted by the July 2012 Stryker Rejuvenate recall, and the June 2012 Smith & Nephew metal liner recall. In addition, Bernstein Liebhard LLP continues to investigate cases concerning the Wright Profemur and Conserve metal hip implants.
Victims of metallosis, hip implant failure, and other serious complications allegedly caused by metal-on-metal hip replacements may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. For more information on filing a Biomet hip replacement lawsuit, as well as additional information regarding complications associated with metal-on-metal hip implants, please visit Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 1-877-779-1414.
About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP